{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,12]],"date-time":"2026-10-12T14:15:48Z","timestamp":1791814548110,"version":"4.3.4"},"reference-count":29,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","funder":[{"name":"Alumni Department of Ophthalmology, Korea University College of Medicine","award":["N\/A"],"award-info":[{"award-number":["N\/A"]}]}],"content-domain":{"domain":["lww.com","ovid.com"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2024,6]]},"abstract":"<jats:sec>\n            <jats:title>Purpose:<\/jats:title>\n            <jats:p>To investigate the imaging and clinical features of polypoidal choroidal vasculopathy (PCV) with pulsation.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Methods:<\/jats:title>\n            <jats:p>The PCV eyes were classified into pulsatile and nonpulsatile PCV groups according to the pulsation on indocyanine green angiography. Imaging features including the dye filling time of the polyp and clinical features were compared.<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Results:<\/jats:title>\n            <jats:p>A total of 75 eyes were classified into the pulsatile PCV (30 eyes) and the nonpulsatile PCV (45 eyes) groups. The initial filling time and complete filling time of the polyp of the pulsatile PCV group (2.59 \u00b1 0.93 and 8.33 \u00b1 3.42 seconds) were shorter than those of the nonpulsatile PCV group (4.11 \u00b1 1.87 and 10.63 \u00b1 3.81 seconds, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001 and <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.010, respectively). The pigment epithelial detachment height of the pulsatile PCV group (414.90 \u00b1 377.15 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m) was greater than that of the nonpulsatile PCV group (247.81 \u00b1 164.07 <jats:italic toggle=\"yes\">\u00b5<\/jats:italic>m, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.030). The pulsatile PCV group showed a higher prevalence of subretinal hemorrhage (43.33%) after intravitreal injection than the nonpulsatile PCV group (13.95%, <jats:italic toggle=\"yes\">P<\/jats:italic> = 0.005) during 12 months. The mean number of injections during 12 months of the pulsatile PCV group (5.48 \u00b1 1.46) was greater than that of the nonpulsatile PCV group (4.09 \u00b1 1.21, <jats:italic toggle=\"yes\">P<\/jats:italic> &lt; 0.001).<\/jats:p>\n          <\/jats:sec>\n          <jats:sec>\n            <jats:title>Conclusion:<\/jats:title>\n            <jats:p>Eyes with pulsatile PCV showed shorter filling time of the polyp, greater pigment epithelial detachment height, higher prevalence of subretinal hemorrhage, and more intravitreal injection numbers during 12 months. These might suggest that PCV has distinct imaging and clinical features according to the polyp pulsation.<\/jats:p>\n          <\/jats:sec>","DOI":"10.1097\/iae.0000000000004057","type":"journal-article","created":{"date-parts":[[2024,2,3]],"date-time":"2024-02-03T13:00:28Z","timestamp":1706965228000},"page":"1083-1091","update-policy":"https:\/\/doi.org\/10.1097\/lww.0000000000001000","source":"Crossref","is-referenced-by-count":3,"title":["IMAGING AND CLINICAL FEATURES OF PULSATILE POLYPOIDAL CHOROIDAL VASCULOPATHY"],"prefix":"10.1097","volume":"44","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-0107-3151","authenticated-orcid":false,"given":"Kwang-Eon","family":"Choi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Joo","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"So Hyeon","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"276","reference":[{"key":"R1-20250605","doi-asserted-by":"crossref","first-page":"3187","DOI":"10.1167\/iovs.14-16236","article-title":"Toward a specific classification of polypoidal choroidal vasculopathy: idiopathic disease or subtype of age-related macular degeneration","volume":"56","author":"Coscas","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R2-20250605","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/archopht.1997.01100150480005","article-title":"The expanding clinical spectrum of idiopathic polypoidal choroidal vasculopathy","volume":"115","author":"Yannuzzi","year":"1997","journal-title":"Arch Ophthalmol"},{"key":"R3-20250605","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1097\/IAE.0b013e31823beb14","article-title":"Polypoidal choroidal vasculopathy: simultaneous indocyanine green angiography and eye-tracked spectral domain optical coherence tomography findings","volume":"32","author":"Khan","year":"2012","journal-title":"Retina"},{"key":"R4-20250605","doi-asserted-by":"crossref","first-page":"4614","DOI":"10.3390\/jcm11154614","article-title":"Relationship between pachychoroid and polypoidal choroidal vasculopathy","volume":"11","author":"Yamashiro","year":"2022","journal-title":"J Clin Med"},{"key":"R5-20250605","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1097\/IAE.0000000000000742","article-title":"En face imaging of pachychoroid spectrum disorders with swept-source optical coherence tomography","volume":"36","author":"Dansingani","year":"2016","journal-title":"Retina"},{"key":"R6-20250605","doi-asserted-by":"crossref","first-page":"S73","DOI":"10.1097\/IAE.0000000000001346","article-title":"Choroidal morphology in eyes with polypoidal choroidal vasculopathy and normal or subnormal subfoveal choroidal thickness","volume":"36","author":"Lee","year":"2016","journal-title":"Retina"},{"key":"R7-20250605","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1111\/j.1755-3768.2009.01517.x","article-title":"Clinical features and follow-up results of pulsating polypoidal choroidal vasculopathy treated with photodynamic therapy","volume":"88","author":"Byeon","year":"2010","journal-title":"Acta Ophthalmol"},{"key":"R8-20250605","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.oret.2018.08.008","article-title":"Clinicopathologic correlation of aneurysmal type 1 neovascularization in age-related macular degeneration","volume":"3","author":"Li","year":"2019","journal-title":"Ophthalmol Retina"},{"key":"R9-20250605","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1097\/IAE.0b013e31824f91e8","article-title":"EVEREST study: efficacy and safety of verteporfin photodynamic therapy in combination with ranibizumab or alone versus ranibizumab monotherapy in patients with symptomatic macular polypoidal choroidal vasculopathy","volume":"32","author":"Koh","year":"2012","journal-title":"Retina"},{"key":"R10-20250605","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.ophtha.2005.03.017","article-title":"Pulsatile blood flow in the polypoidal choroidal vasculopathy","volume":"112","author":"Okubo","year":"2005","journal-title":"Ophthalmology"},{"key":"R11-20250605","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/j.oret.2017.11.016","article-title":"Indocyanine green dye filling time for polypoidal lesions in polypoidal choroidal vasculopathy affects the visibility of the lesions on OCT angiography","volume":"2","author":"Fukuyama","year":"2018","journal-title":"Ophthalmol Retina"},{"key":"R12-20250605","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1097\/IAE.0000000000002583","article-title":"Difference between pachychoroid and nonpachychoroid polypoidal choroidal vasculopathy and their response to anti-vascular endothelial growth factor therapy","volume":"40","author":"Chang","year":"2020","journal-title":"Retina"},{"key":"R13-20250605","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1167\/iovs.16-19375","article-title":"Estimating mean ocular perfusion pressure using mean arterial pressure and intraocular pressure","volume":"57","author":"Van Keer","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R14-20250605","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1136\/bjo.2004.049296","article-title":"The origins of polypoidal choroidal vasculopathy","volume":"89","author":"Yuzawa","year":"2005","journal-title":"Br J Ophthalmol"},{"key":"R15-20250605","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/j.ophtha.2020.08.006","article-title":"Polypoidal choroidal vasculopathy: consensus nomenclature and non-indocyanine green angiograph diagnostic criteria from the Asia-Pacific Ocular Imaging Society PCV Workgroup","volume":"128","author":"Cheung","year":"2021","journal-title":"Ophthalmology"},{"key":"R16-20250605","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1007\/s00417-013-2419-z","article-title":"Reduction in choroidal thickness of macular area in polypoidal choroidal vasculopathy patients after intravitreal ranibizumab therapy","volume":"251","author":"Nishide","year":"2013","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R17-20250605","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1007\/s00417-020-04957-5","article-title":"Short-term choroidal vascular changes after aflibercept therapy for neovascular age-related macular degeneration","volume":"259","author":"Pellegrini","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R18-20250605","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10384-007-0498-2","article-title":"Incidence and clinical patterns of polypoidal choroidal vasculopathy in Korean patients","volume":"52","author":"Byeon","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"R19-20250605","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1007\/s00417-021-05525-1","article-title":"Clinicopathological study of the polypoidal lesions of polypoidal choroidal vasculopathy","volume":"260","author":"Liu","year":"2022","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R20-20250605","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.ajo.2009.01.024","article-title":"A variable-dosing regimen with intravitreal ranibizumab for neovascular age-related macular degeneration: year 2 of the PrONTO Study","volume":"148","author":"Lalwani","year":"2009","journal-title":"Am J Ophthalmol"},{"key":"R21-20250605","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1111\/aos.12653","article-title":"Association between choroidal thickness and the response to intravitreal ranibizumab injection in age-related macular degeneration","volume":"93","author":"Shin","year":"2015","journal-title":"Acta Ophthalmol"},{"key":"R22-20250605","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1097\/IAE.0000000000001427","article-title":"Choroidal thickness as a prognostic factor of photodynamic therapy with aflibercept or ranibizumab for polypoidal choroidal vasculopathy","volume":"37","author":"Sakurada","year":"2017","journal-title":"Retina"},{"key":"R23-20250605","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1007\/s00417-020-04924-0","article-title":"Clinical characteristics of super stable polypoidal choroidal vasculopathy after initial remission with anti-VEGF monotherapy","volume":"259","author":"Choi","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"R24-20250605","doi-asserted-by":"crossref","first-page":"326","DOI":"10.2174\/1874364101711010326","article-title":"Polypoidal choroidal vasculopathy in highly myopic eyes with elongated axial length","volume":"11","author":"Kokame","year":"2017","journal-title":"Open Ophthalmol J"},{"key":"R25-20250605","doi-asserted-by":"crossref","first-page":"100973","DOI":"10.1016\/j.preteyeres.2021.100973","article-title":"Venous overload choroidopathy: a hypothetical framework for central serous chorioretinopathy and allied disorders","volume":"86","author":"Spaide","year":"2022","journal-title":"Prog Retin Eye Res"},{"key":"R26-20250605","doi-asserted-by":"crossref","first-page":"4405","DOI":"10.2147\/OPTH.S334641","article-title":"Visual outcome and treatment frequency of anti-VEGF therapy using the treat-and-extend and treatment cessation regimen for exudative age-related macular degeneration and pachychoroid neovasculopathy","volume":"15","author":"Kinoshita","year":"2021","journal-title":"Clin Ophthalmol"},{"key":"R27-20250605","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1097\/IAE.0000000000003595","article-title":"Predictors and importance of complete polypoidal lesion regression in the EVEREST II study: predictors of polyp regression in polypoidal choroidal vasculopathy","volume":"42","author":"Tan","year":"2022","journal-title":"Retina"},{"key":"R28-20250605","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/S0002-9394(00)00643-7","article-title":"The role of the atherosclerotic process in the pathogenesis of age-related macular degeneration","volume":"130","author":"Friedman","year":"2000","journal-title":"Am J Ophthalmol"},{"key":"R29-20250605","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1167\/iovs.63.9.13","article-title":"Choriocapillaris flow imbalance in fellow eyes in age-related macular degeneration","volume":"63","author":"Harada","year":"2022","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["Retina"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004057","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,5]],"date-time":"2025-06-05T17:02:25Z","timestamp":1749142945000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/10.1097\/IAE.0000000000004057"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024]]}},"URL":"https:\/\/doi.org\/10.1097\/iae.0000000000004057","relation":{},"ISSN":["0275-004X"],"issn-type":[{"value":"0275-004X","type":"print"}],"subject":[],"published":{"date-parts":[[2024,6]]}}}